Mark Waer
10Patents
5h-index
15Co-inventors
63Inventor score
Filing activity: Sep 1, 1994 → Oct 20, 2014
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7276506B2 | Immunosuppressive effects of pteridine derivatives | Chemistry; Metallurgy | 18 | Expired |
| US7501513B2 | Immunosuppressive effects of pteridine derivatives | Chemistry; Metallurgy | 17 | Expired |
| US6946465B2 | Immunosuppressive effects of pteridine derivatives | Chemistry; Metallurgy | 17 | Expired |
| US5665387A | Methods and compositions for primary and secondary prevention of autoimmune diabetes | Human Necessities | 13 | Expired |
| US6432968B1 | Combination preparation, containing cyclosporin a or FK506 or rapamycin and a xanthine derivative | Human Necessities | 8 | Expired |
| US7253176B1 | Immunosuppressive effects of 8-substituted xanthine derivatives | Human Necessities | 4 | Expired |
| US8901132B2 | Thiazolopyrimidine modulators as immunosuppressive agents | Chemistry; Metallurgy | 4 | Active |
| US6046328A | Combination preparation, containing cyclosporin A or FK506 or rapamycin and a xanthine derivative | Human Necessities | 2 | Expired |
| US9221822B2 | Thiazolopyrimidine modulators as immunosuppressive agents | Chemistry; Metallurgy | 1 | Active |
| US9301961B2 | Autoimmune and inflammatory disorder therapy | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.